- Home
- RLAY vs GES Comparison
RLAY vs GES Comparison
Compare RLAY & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- GES
- Stock Information
- Founded
- RLAY 2015
- GES 1981
- Country
- RLAY United States
- GES Switzerland
- Employees
- RLAY N/A
- GES N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- GES Apparel
- Sector
- RLAY Health Care
- GES Consumer Discretionary
- Exchange
- RLAY Nasdaq
- GES Nasdaq
- Market Cap
- RLAY 610.3M
- GES 628.9M
- IPO Year
- RLAY 2020
- GES 1996
- Fundamental
- Price
- RLAY $3.74
- GES $13.64
- Analyst Decision
- RLAY Strong Buy
- GES Buy
- Analyst Count
- RLAY 11
- GES 4
- Target Price
- RLAY $18.40
- GES $17.75
- AVG Volume (30 Days)
- RLAY 2.3M
- GES 601.6K
- Earning Date
- RLAY 08-05-2025
- GES 08-27-2025
- Dividend Yield
- RLAY N/A
- GES 8.80%
- EPS Growth
- RLAY N/A
- GES N/A
- EPS
- RLAY N/A
- GES 0.10
- Revenue
- RLAY $7,679,000.00
- GES $3,051,131,000.00
- Revenue This Year
- RLAY $17.59
- GES $7.34
- Revenue Next Year
- RLAY N/A
- GES $3.20
- P/E Ratio
- RLAY N/A
- GES $141.08
- Revenue Growth
- RLAY N/A
- GES 9.02
- 52 Week Low
- RLAY $1.78
- GES $8.48
- 52 Week High
- RLAY $10.72
- GES $24.33
- Technical
- Relative Strength Index (RSI)
- RLAY 58.29
- GES 61.64
- Support Level
- RLAY $3.47
- GES $12.69
- Resistance Level
- RLAY $3.97
- GES $13.75
- Average True Range (ATR)
- RLAY 0.20
- GES 0.51
- MACD
- RLAY -0.00
- GES 0.02
- Stochastic Oscillator
- RLAY 54.00
- GES 93.75
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About GES Guess? Inc.
Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.